Information

You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

loading
A Phase I Clinical Trial with a Novel gp41 HIV Vaccine (EN41-FPA2) in Healthy Female Volunteers: A Mucosal Prime and Intramuscular Boost Regimen